| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $151K | -53.3% | -66.4% |
| SG&A Expense | $318K | -18.7% | +3.5% |
| Operating Income | -$470K | +35.8% | +63.9% |
| Pre-tax Income | -$654K | +13.9% | +64.2% |
| Net Income | -$654K | +13.9% | +64.2% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $251K | +126.1% | -79.8% |
| Total Assets | $271K | +104.5% | -78.6% |
| Current Liabilities | $2.4M | +47.7% | +172.6% |
| Total Liabilities | $2.6M | +44.1% | +189.9% |
| Stockholders' Equity | -$2.3M | -39.3% | -719.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | — |
| Capital Expenditures | $26K | — | — |
| Investing Cash Flow | -$26K | — | — |
| Financing Cash Flow | $1.1M | — | — |
| Free Cash Flow | -$1.4M | — | — |
| — |